All AbMole products are for research use only, cannot be used for human consumption.
Atomoxetine is a selective norepinephrine (NE) transporter inhibitor with Ki of 5 nM, with 15- and 290-fold lower affinity for human 5-HT and DA transporters.
 . figure 6.jpg) |
Source | Cephalalgia (2017) . Figure 6. Sumatriptan (Abmole Bioscience, Houston, TX, USA) |
| Method | s.c. with osmotic minipump | |
| Cell Lines | Adult male Sprague-Dawley rats | |
| Concentrations | 0.6 mg/kg/day | |
| Incubation Time | 7 days | |
| Results | Right, but not left, CeA injection of the KOR agonist produced allodynia in sumatriptan-primed rats. |
 . figure 4.jpg) |
Source | Cephalalgia (2017) . Figure 4. Sumatriptan (Abmole Bioscience, Houston, TX, USA) |
| Method | s.c. with osmotic minipump | |
| Cell Lines | Adult male Sprague-Dawley rats | |
| Concentrations | 0.6 mg/kg/day | |
| Incubation Time | 7 days | |
| Results | Nor-BNI administration into the right, but not left, CeA blocked BLS-induced allodynia. |
 . figure 3.jpg) |
Source | Cephalalgia (2017) . Figure 3. Sumatriptan (Abmole Bioscience, Houston, TX, USA) |
| Method | s.c. with osmotic minipump | |
| Cell Lines | Adult male Sprague-Dawley rats | |
| Concentrations | 0.6 mg/kg/day | |
| Incubation Time | 7 days | |
| Results | BLS increases dynorphin content and pKOR expression in the central nucleus of amygdala (CeA). |
 . figure 2.jpg) |
Source | Cephalalgia (2017) . Figure 2. Sumatriptan (Abmole Bioscience, Houston, TX, USA) |
| Method | s.c. with osmotic minipump | |
| Cell Lines | Adult male Sprague-Dawley rats | |
| Concentrations | 0.6 mg/kg/day | |
| Incubation Time | 7 days | |
| Results | Oral CYM51317 administration before BLS prevented cephalic and extracephalic cutaneous allodynia. |
 . figure 1.jpg) |
Source | Cephalalgia (2017) . Figure 1. Sumatriptan (Abmole Bioscience, Houston, TX, USA) |
| Method | s.c. with osmotic minipump | |
| Cell Lines | Adult male Sprague-Dawley rats | |
| Concentrations | 0.6 mg/kg/day | |
| Incubation Time | 7 days | |
| Results | Systemic KOR antagonist nor-BNI prevented stress-induced cephalic and extracephalic allodynia. Systemic KOR antagonist nor-BNI blocked stress-induced increase in plasma CGRP. |
| Molecular Weight | 291.82 |
| Formula | C17H21NO.HCl |
| CAS Number | 82248-59-7 |
| Solubility (25°C) | DMSO 40 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Samuele Cortese. Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder
| Related 5-HT Receptor Products |
|---|
| Buspirone
Buspirone is an orally active 5-HT1A receptor agonist, and a dopamine D2 autoreceptorsant antagonist. |
| Clomipramine Hydrochloride
Clomipramine HCl is a hydrochloride salt of clomipramine which is a serotonin transporter (SERT), norepinephrine transporter (NET) dopamine transporter (DAT) blocker with Ki of 0.14, 54 and 3 nM, respectively. |
| Quetiapine Sulfone
Quetiapine Sulfone is a 5-HT receptor agonist with a pEC50 value of 4.77 for human 5-HT1A. Quetiapine hemifumarate is a dopamine receptor antagonist with a pIC50 value of 6.33 for human D2. |
| Quetiapine sulfoxide
Quetiapine sulfoxide is a 5-HT receptor agonist with a pEC50 value of 4.77 for human 5-HT1A. Quetiapine hemifumarate is a dopamine receptor antagonist with a pIC50 value of 6.33 for human D2. |
| Iloperidone
Iloperidone, a serotonin (5-HT2) receptor inhibitor, is used to study schizophrenia. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
